Amicus Therapeutics, Inc.Cranbury, NJ, United States (NASDAQ (GM): FOLD)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Amicus Therapeutics Income Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 07 Dec 06 Dec 05
Revenue 1.8 0.0 0.0
Cost of Goods Sold -- -- --
Gross Profit -- -- --
Gross Profit Margin 0.0% 0.0% 0.0%
SG&A Expense 46.3 45.9 20.2
Depreciation & Amortization 1.2 0.9 0.7
Operating Income (45.8) (46.9) (20.8)
Operating Margin -- -- --
Nonoperating Income 5.0 0.8 0.3
Nonoperating Expenses 0.3 0.3 0.1
Income Before Taxes (41.2) (46.3) (20.6)
Income Taxes -- -- (0.6)
Net Income After Taxes (41.2) (46.3) (20.0)

Continuing Operations (41.2) (46.3) (20.0)
Discontinued Operations -- -- --
Total Operations (41.2) (46.3) (20.0)
Total Net Income (41.2) (46.3) (20.0)
Net Profit Margin -- -- --

Diluted EPS from Total Net Income ($) (3.14) (89.58) --
Dividends per Share -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online